ClinicalTrials.gg
CompletedNCT07038148Updated Nov 3, 2026

Single-Stage Stapled Conversion of Gastric Bypass to Sleeve Gastrectomy

An interventional study of Single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy in Gastric Bypass Complication, Obesity and Bariatric Surgery Candidate, sponsored by Kasr El Aini Hospital. Completed at 1 site in Egypt. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Kasr El Aini Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Nov 3, 2026Now CompletedStart date moved+9 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 138 studies in Obesity with a site in Egypt — 32 open to participants now, 39 under way, none of them phase 3. Obesity · Egypt.

Enrollment
98th of 102
11 · median 60
Started
2025
with 22 others
No phase
90 of 138
21 open now
Registered
94th of 138
by date
Lead sponsor
6 of 138
Kasr El Aini Hospital

Among the 138 studies in Obesity with a site in Egypt, this one is the 98th largest by enrollment of the 102 interventional ones that give a count, is one of 23 that started in 2025, is one of 90 with no phase, and was the 94th registered.

Obesity

11,560 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

32 of the 138 studies in Obesity with a site in Egypt are open now. Recruiting first, the newest first:

27 more — sign in →

All 32 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 138 studies in Obesity with a site in Egypt, or all of them as a file.
02

Study summary

Some patients who have had a gastric bypass (Roux-en-Y gastric bypass or one anastomosis gastric bypass) develop long-term problems such as nutritional deficiencies, intractable dumping syndrome, retrograde intussusception or weight regain, and some cannot afford the lifelong vitamin supplements the bypass requires. When these problems do not respond to non-surgical treatment, the bypass can be reversed to normal anatomy, but many patients refuse reversal because they fear regaining weight. Converting the bypass to a sleeve gastrectomy is an alternative that restores food passage through the duodenum while keeping a restrictive operation.

This single-arm study evaluates the efficacy, safety and patient outcomes of single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy in adults at Kasr Al-Ainy hospitals, Cairo University. Patients are followed for 6 months after surgery for nutritional status, weight regain, quality of life, reflux (GERD) symptoms and postoperative complications, including leak.

Read the detailed description

Background: Laparoscopic gastric bypass, including Roux-en-Y gastric bypass (RYGB) and one anastomosis gastric bypass (OAGB), is one of the most frequently performed metabolic bariatric procedures. As the number of bypass operations increases, complications are reported more often. Most can be managed non-surgically, but a small number of persistent cases require reversal to normal anatomy or conversion to another procedure. Complications that may require conversion include retrograde intussusception, weight regain, intractable dumping syndrome and nutritional deficiencies; the high cost of obligatory postoperative vitamins is a further reason for conversion in low-income countries. Conversion is technically demanding, carries a relatively higher rate of postoperative complications, and data on its outcomes are limited.

Design: Prospective, single-arm interventional study.

Preoperative assessment: Patients attending the bariatric outpatient clinic who meet the eligibility criteria are enrolled after patient education. History, anthropometric measures, chronic diseases and previous surgeries are recorded. Routine preoperative laboratory tests and imaging are performed, together with a preoperative 3D CT gastric volumetry.

Surgical technique: After pneumoperitoneum and laparoscopic port placement, the previous gastrojejunostomy is closed with an endostapler applied across the anastomosis and fired on the jejunal side. The end of the gastric pouch is then anastomosed to the remnant stomach with an endostapler. A 36 Fr orogastric tube is passed through the anastomosis as a guide, and a sleeve gastrectomy is performed by resecting the stomach along the greater curvature with endostaplers. An intraoperative methylene blue leak test is performed, hemostasis along the staple line is confirmed, and all ports are closed.

Postoperative care and follow-up: Patients stay in hospital for about 24 hours for monitoring of vital signs and the feeding regimen. Nutritional laboratory parameters (hemoglobin, ferritin, vitamin D, zinc, magnesium, serum albumin and calcium), quality of life (Bariatric Quality of Life Index) and GERD symptoms (GERD-HRQL questionnaire) are assessed at 3 and 6 months after surgery. Body weight is recorded monthly to assess weight regain.

Sample size: Calculated with the ClinCalc sample size calculator (alpha 0.05, power 0.80) as 11 patients, including 10% to cover loss to follow-up. A convenience sample of eligible patients is enrolled until this number is reached.

Statistical analysis: SPSS version 21. Categorical data as number and percentage; quantitative data as mean and standard deviation or median and interquartile range. Chi-square, Student t and Mann-Whitney tests, with correlation and regression analysis. Significance at p of 0.05 or less.

03

Conditions studied

  • Gastric Bypass Complication
  • Obesity
  • Bariatric Surgery Candidate

Keywords

  • Conversion of gastric bypass
  • Revisional metabolic bariatric surgery
  • Sleeve gastrectomy
  • Roux-en-Y gastric bypass
  • One anastomosis gastric bypass
  • Staple line leak
  • Dumping syndrome
  • Weight regain
04

Who can participate

The criteria were revised on the registry on Nov 3, 2026. See what changed

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 70 years
  • Adult patients with a previous gastric bypass undergoing single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy

Exclusion criteria

Exclusion Criteria:

  • Reversal of gastric bypass to normal anatomy
  • Uncontrolled systemic disease
  • Active psychological disorder
  • Intraoperative technical difficulties preventing conversion of gastric bypass to sleeve gastrectomy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Conversion to sleeve gastrectomy

    Adults with a previous gastric bypass (RYGB or OAGB) undergoing single-stage laparoscopic stapled conversion to sleeve gastrectomy.

    Procedure: Single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy

Interventions

  • ProcedureSingle-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy

    Stapled closure of the previous gastrojejunostomy on the jejunal side, stapled anastomosis of the gastric pouch to the remnant stomach, then sleeve gastrectomy along the greater curvature over a 36 Fr orogastric tube, with an intraoperative methylene blue leak test.

06

What researchers measure

Primary outcomes

  1. Postoperative leak

    Number of participants with a staple-line or anastomotic leak after single-stage stapled conversion of gastric bypass to sleeve gastrectomy.

    Time frame: From surgery up to 6 months after surgery

  2. Change in nutritional status

    Nutritional status assessed with laboratory parameters: hemoglobin, serum ferritin, vitamin D, zinc, magnesium, serum albumin and calcium.

    Time frame: Preoperatively, and at 3 and 6 months after surgery

  3. Weight regain

    Body weight (kg) recorded monthly after conversion to assess weight regain.

    Time frame: Monthly from surgery up to 6 months after surgery

Secondary outcomes

  1. Quality of life (Bariatric Quality of Life Index)

    Quality of life assessed with the Bariatric Quality of Life (BQL) Index.

    Time frame: 3 and 6 months after surgery

  2. GERD symptoms (GERD-Health Related Quality of Life questionnaire)

    Gastroesophageal reflux symptoms assessed with the GERD-Health Related Quality of Life (GERD-HRQL) questionnaire.

    Time frame: 3 and 6 months after surgery

  3. Other postoperative complications

    Number of participants with postoperative complications other than leak, including bleeding and stricture.

    Time frame: From surgery up to 6 months after surgery

07

Study locations

1 site
  • Kasr Alaini Hospital
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2025 to primary completion in Oct 2026, 19 months.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 19 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

Start moved once since we started tracking on Sep 25, 2026: Jan 2025 → Feb 2025, on Nov 3, 2026.

Primary completion moved twice since we started tracking on Sep 25, 2026: Jan 2026 → Oct 2026, last on Nov 3, 2026.

Completion moved twice since we started tracking on Sep 25, 2026: Jan 2026 → Oct 2026, last on Nov 3, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 25, 2025
First posted
Jun 26, 2025
StartActual
Feb 18, 2025was Jan 2025
Primary completionActual
Oct 1, 2026was Jan 2026
CompletionActual
Oct 1, 2026was Jan 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 26, 2026
Sites
1 site added, 1 site removed
Show site
  • Kasr Alaini Hospital · Cairo, Egypt
Show 1 removed
  • Kasr Alainy Medical School, Cairo University · Cairo, Egypt
Nov 3, 2026
Start date
Jan 25, 2025→Feb 18, 2025
Nov 3, 2026
Primary completion
Jan 25, 2026→Oct 1, 2026
moved 2 times, Oct 26, 2026 – Nov 3, 2026
Study completion
Jan 30, 2026→Oct 1, 2026
moved 2 times, Oct 26, 2026 – Nov 3, 2026
Eligibility
2 inclusion criteria edited, 1 removed; 3 exclusion criteria edited, 1 added, 3 removed
What changed in the criteria
Inclusion criteria
  • EditedAge between 18-18 to 70 years
  • EditedAdult patients with a previous gastric bypass undergoing single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy.
  • RemovedPatients accept to sign an informed consent and will commit to follow-up.
Exclusion criteria
  • EditedPatients with reversalReversal of gastric bypass to normal anatomy.
  • EditedPatient with uncontrolledUncontrolled systemic disease.
  • RemovedPatients with active psychological disorders.
  • RemovedPatients with active substance abuse.
  • AddedActive psychological disorder
  • EditedPatients with intra-operativeIntraoperative technical difficulties hindering thepreventing conversion of gastric bypass to sleeve gastrectomy.
  • RemovedPatients refusing to sign an informed consent.
Nov 3, 2026
Interventions
Added Procedure: Single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy; removed Procedure: Stapled reversal of gastric bypass to sleeve gastrectomy utilising stapling technique.. Arms added: Conversion to sleeve gastrectomy; arms removed: Candidates of several of bypass to sleeve
Nov 3, 2026
Primary outcomes
Revised in 2 updates
What changed on Oct 26, 2026
  • AddedIncidence of leakageTime frame: within two weeks after the surgery
What changed on Nov 3, 2026
  • EditedNutritional StatusChange in nutritional statusTime frame: one year → Preoperatively, and at 3 and 6 months after surgery
  • EditedWeight RegainregainTime frame: one year → Monthly from surgery up to 6 months after surgery
  • ChangedBefore Incidence of leakageNow Postoperative leakTime frame: within two weeks after the surgery → From surgery up to 6 months after surgery
across 2 updates, Oct 26, 2026 – Nov 3, 2026
Secondary outcomes
3 added, 3 removed
What changed in the outcomes
  • AddedQuality of life (Bariatric Quality of Life Index)Time frame: 3 and 6 months after surgery
  • AddedGERD symptoms (GERD-Health Related Quality of Life questionnaire)Time frame: 3 and 6 months after surgery
  • AddedOther postoperative complicationsTime frame: From surgery up to 6 months after surgery
  • RemovedQuality of LifeTime frame: one year
  • RemovedGERG symptomsTime frame: One year
  • Removedother outcomePossible RisksTime frame: One year
Nov 3, 2026
Title
Exploring the Efficacy of Single-stageStage Stapled Conversion of Gastric Bypass to Sleeve Gastrectomy, More Leak?
Nov 3, 2026
Show all 2 updates
  1. Nov 3, 2026
    1 site added, 1 site removed
    Show site
    • Kasr Alaini Hospital · Cairo, Egypt
    Show 1 removed
    • Kasr Alainy Medical School, Cairo University · Cairo, Egypt
    Start date Jan 25, 2025→Feb 18, 2025
    Primary completion Sep 20, 2026→Oct 1, 2026
    Study completion Sep 20, 2026→Oct 1, 2026
    Eligibility 2 inclusion criteria edited, 1 removed; 3 exclusion criteria edited, 1 added, 3 removed
    What changed in the criteria
    Inclusion criteria
    • EditedAge between 18-18 to 70 years
    • EditedAdult patients with a previous gastric bypass undergoing single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy.
    • RemovedPatients accept to sign an informed consent and will commit to follow-up.
    Exclusion criteria
    • EditedPatients with reversalReversal of gastric bypass to normal anatomy.
    • EditedPatient with uncontrolledUncontrolled systemic disease.
    • RemovedPatients with active psychological disorders.
    • RemovedPatients with active substance abuse.
    • AddedActive psychological disorder
    • EditedPatients with intra-operativeIntraoperative technical difficulties hindering thepreventing conversion of gastric bypass to sleeve gastrectomy.
    • RemovedPatients refusing to sign an informed consent.
    Primary outcomes 3 edited
    What changed in the outcomes
    • EditedNutritional StatusChange in nutritional statusTime frame: one year → Preoperatively, and at 3 and 6 months after surgery
    • EditedWeight RegainregainTime frame: one year → Monthly from surgery up to 6 months after surgery
    • ChangedBefore Incidence of leakageNow Postoperative leakTime frame: within two weeks after the surgery → From surgery up to 6 months after surgery
    Secondary outcomes 3 added, 3 removed
    What changed in the outcomes
    • AddedQuality of life (Bariatric Quality of Life Index)Time frame: 3 and 6 months after surgery
    • AddedGERD symptoms (GERD-Health Related Quality of Life questionnaire)Time frame: 3 and 6 months after surgery
    • AddedOther postoperative complicationsTime frame: From surgery up to 6 months after surgery
    • RemovedQuality of LifeTime frame: one year
    • RemovedGERG symptomsTime frame: One year
    • Removedother outcomePossible RisksTime frame: One year
    Interventions Added Procedure: Single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy; removed Procedure: Stapled reversal of gastric bypass to sleeve gastrectomy utilising stapling technique.. Arms added: Conversion to sleeve gastrectomy; arms removed: Candidates of several of bypass to sleeve
    Title Exploring the Efficacy of Single-stageStage Stapled Conversion of Gastric Bypass to Sleeve Gastrectomy, More Leak?
    + 10 other changes: index terms, verification date, responsible party, oversight details, description, conditions, design details, contact details, references and data sharing statement
  2. Oct 26, 2026
    Recruiting→Completed
    Primary completion Jan 25, 2026→Sep 20, 2026 (now actual)
    Study completion Jan 30, 2026→Sep 20, 2026 (now actual)
    Primary outcomes 1 added
    What changed in the outcomes
    • AddedIncidence of leakageTime frame: within two weeks after the surgery
    + 3 other changes: oversight details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07038148
Responsible party
Ahmed Abdelsalam M (Associate Professor of General Surgery, Cairo University) — Principal investigator
First posted
Jun 26, 2025
Start date
Feb 18, 2025
Primary completion
Oct 1, 2026
Completion
Oct 1, 2026
Last update
Nov 3, 2026

Study contacts

Ahmed Mohamed Abdelsalam, MD
principal investigator · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion